189 related articles for article (PubMed ID: 37031273)
1. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer.
Shi L; Duan R; Sun Z; Jia Q; Wu W; Wang F; Liu J; Zhang H; Xue X
Cell Death Differ; 2023 Jun; 30(6):1517-1532. PubMed ID: 37031273
[TBL] [Abstract][Full Text] [Related]
2. STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis.
Huo N; Cong R; Sun ZJ; Li WC; Zhu X; Xue CY; Chen Z; Ma LY; Chu Z; Han YC; Kang XF; Jia SH; Du N; Kang L; Xu XJ
Cell Death Dis; 2021 Aug; 12(9):799. PubMed ID: 34404767
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
4. LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.
Hou X; Shi X; Zhang W; Li D; Hu L; Yang J; Zhao J; Wei S; Wei X; Ruan X; Zheng X; Gao M
Cell Death Dis; 2021 Apr; 12(4):347. PubMed ID: 33795650
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151-5p/WNT7A axis.
Bai D; Guo C; Wang A; Pang G; Gao J; Wang C; Zhao D; Yang J; Ren J
Pathol Res Pract; 2021 Sep; 225():153561. PubMed ID: 34325316
[TBL] [Abstract][Full Text] [Related]
6. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
7. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
Zhao Y; Zhao L; Li J; Zhong L
J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
[TBL] [Abstract][Full Text] [Related]
8. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
Gao H; Sun X; Wang H; Zheng Y
Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis.
Fan Y; Fan X; Yan H; Liu Z; Wang X; Yuan Q; Xie J; Lu X; Yang Y
Cell Death Dis; 2022 Feb; 13(2):157. PubMed ID: 35173149
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
Song B; Li R; Zuo Z; Tan J; Liu L; Ding D; Lu Y; Hou D
BMC Cancer; 2019 Apr; 19(1):297. PubMed ID: 30940124
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.
Liu C; Feng Z; Chen T; Lv J; Liu P; Jia L; Zhu J; Chen F; Yang C; Deng Z
Cell Cycle; 2019 Jan; 18(2):167-203. PubMed ID: 30596336
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.
Shao L; Sun W; Wang Z; Dong W; Qin Y
IUBMB Life; 2020 Feb; 72(2):237-246. PubMed ID: 31478331
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNAs SET-binding factor 2-antisense RNA1 promotes cell growth through targeting miR-431-5p/CDK14 axis in human papillary thyroid cancer.
Wen HL; Xu ZM; Wen D; Lin SY; Liang Y; Xie JP
Kaohsiung J Med Sci; 2020 Oct; 36(10):808-816. PubMed ID: 32602632
[TBL] [Abstract][Full Text] [Related]
15. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3.
Zhao Y; Feng X; Zhao Y; Yang H; Zhang C
Mol Biotechnol; 2023 Mar; 65(3):477-490. PubMed ID: 36030355
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs.
Lin RX; Yang SL; Jia Y; Wu JC; Xu Z; Zhang H
Semin Cancer Biol; 2022 Aug; 83():253-260. PubMed ID: 33785446
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HULC exerts oncogenic activity on papillary thyroid cancer
Yang Z; Li G; Ding C; Sun W; Zhang J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):326-335. PubMed ID: 31878795
[TBL] [Abstract][Full Text] [Related]
19. LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer.
Gao Y; Wang F; Zhang L; Kang M; Zhu L; Xu L; Liang W; Zhang W
Cancer Med; 2020 Feb; 9(4):1515-1528. PubMed ID: 31894666
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PFAR facilitates the proliferation and migration of papillary thyroid carcinoma by competitively binding to miR-15a.
Fang T; Yu K
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3037-3048. PubMed ID: 37874339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]